en.Wedoany.com Reported - The Third Annual Academic Conference of the Beijing Medical Association Nuclear Medicine Specialist Branch was held from May 30 to 31, 2026, at the Beijing Guoyi Hotel. The conference was hosted by the Beijing Medical Association, organized by the Beijing Medical Association Nuclear Medicine Specialist Branch, and co-organized by Beijing Friendship Hospital, Capital Medical University.

At 8:00 AM on May 30, the opening ceremony took place in the Yihe Hall on the north building of the Guoyi Hotel. The ceremony was chaired by Professor Yang Jigang, President of the Beijing Medical Association Nuclear Medicine Specialist Branch and from Beijing Friendship Hospital, Capital Medical University. Speeches were delivered successively by Professor Li Sijin, former President of Shanxi Medical University; Professor Liu Fugeng, President-elect of the Chinese Medical Association Nuclear Medicine Specialist Branch; Professor Yang Zhi, Chairman of the Beijing Medical Association Nuclear Medicine Branch; Professor Huo Li, first President of the Beijing Medical Association Nuclear Medicine Specialist Branch; Professor Yang Yingchi, Vice President of Beijing Friendship Hospital, Capital Medical University; and Professor Xu Junfeng, Vice President of the Beijing Medical Association. The conference lasted two days, with participating institutions including Beijing Hospital, Chinese PLA General Hospital, Peking Union Medical College Hospital, Peking University Cancer Hospital, West China Hospital of Sichuan University, Shanghai Changhai Hospital, First Hospital of Shanxi Medical University, Union Hospital of Huazhong University of Science and Technology, Peking University Third Hospital, and Beijing Friendship Hospital, Capital Medical University.

On the morning of May 30, Professor Li Sijin delivered a special report on "Opportunities and Challenges in the Development of Nuclear Medicine"; Professor Zuo Changjing reported on "Clinical Applications and Advances of AI-Based PET Imaging"; Professor Yang Zhi presented "Progress in B7H3-Targeted Radiopharmaceutical Research and Practice at Peking University Cancer Hospital"; and Professor Huo Li shared "Thoughts on the Development of Radionuclide Diagnosis and Treatment for Prostate Cancer in China." Professors Tian Rong, Wu Hubing, and Ouyang Wei reported on the application of PET/MR in radiotherapy, preliminary clinical application of GPC3-targeted imaging for hepatocellular carcinoma, and opportunities and challenges in radionuclide therapy ward management, respectively. That afternoon, Professor Huang Gang, President of the Chinese Medical Association Nuclear Medicine Physician Branch, delivered a report on the safety of clinical research and translation of nuclear drugs. Professors Yin Yafu, Pang Hua, Hu Shuo, Zhu Xiaohua, Zhang Guoxu, and Hu Kuan reported on topics including the application of FAPI PET in the cardiovascular system, the use of nuclear medicine molecular imaging in adrenal disease diagnosis and treatment, the value of nuclear medicine techniques in prostate cancer treatment decisions, exploration of Total-body PET/CT dynamic imaging in proton therapy verification, precise diagnosis and treatment of differentiated thyroid cancer after surgery, and the development and clinical translation of peptide-based nuclear drugs.

On the morning of May 31, Professor Lan Xiaoli reported on "Integrated Tumor Diagnosis and Therapy with Dual-Target Radiopharmaceuticals"; Professor Xu Yanfeng shared "Artificial Intelligence Empowering Structured Reports in Nuclear Medicine"; Professor Yu Chunjing explained the implementation pathway for investigator-initiated clinical studies; and Professor Shi Feng introduced the application of radioactive iodine-125 seed combined with targeted therapy in refractory thyroid cancer. The conference also featured discussions on the value of PET/CT in nasopharyngeal carcinoma, the design, synthesis, and translation of FAP-targeted pyridine scaffold-based radiopharmaceuticals, nuclear medicine diagnostic and treatment pathways after differentiated thyroid cancer surgery, and clinical practice guidelines for 18F-FDG PET/CT in guiding lung cancer radiotherapy. The annual conference concluded at noon on May 31.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com